SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-13-004085
Filing Date
2013-01-25
Accepted
2013-01-25 17:10:13
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO S-3 v332025_s3a.htm S-3/A 318204
2 EXHIBIT 4.4 v332025_ex4-4.htm EX-4.4 298216
3 EXHIBIT 4.5 v332025_ex4-5.htm EX-4.5 335983
4 EXHIBIT 5.1 v332025_ex5-1.htm EX-5.1 26785
5 EXHIBIT 23.1 v332025_ex23-1.htm EX-23.1 3410
7 GRAPHIC tlogo.jpg GRAPHIC 21610
8 GRAPHIC logo.jpg GRAPHIC 4796
9 GRAPHIC footer.jpg GRAPHIC 5577
10 filename10.htm CORRESP 11976
  Complete submission text file 0001144204-13-004085.txt   1040093
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-185898 | Film No.: 13549421
SIC: 2834 Pharmaceutical Preparations